Chemoinformaics analysis of 1-HYDROXY-2,3,4,7-TETRAMETHOXYXANTHEN-9-ONE
| Molecular Weight | 332.308 | nRot | 4 |
| Heavy Atom Molecular Weight | 316.18 | nRig | 17 |
| Exact Molecular Weight | 332.09 | nRing | 3 |
| Solubility: LogS | -3.668 | nHRing | 1 |
| Solubility: LogP | 2.676 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 16 |
| nHA | 7 | APOL | 44.6727 |
| nHD | 1 | BPOL | 25.5993 |
| QED | 0.735 |
| Synth | 2.406 |
| Natural Product Likeliness | 1.087 |
| NR-PPAR-gamma | 0.647 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.995 |
| Pgp-sub | 0 |
| HIA | 0.014 |
| CACO-2 | -4.685 |
| MDCK | 0.000032 |
| BBB | 0.036 |
| PPB | 0.761299 |
| VDSS | 1.019 |
| FU | 0.265542 |
| CYP1A2-inh | 0.611 |
| CYP1A2-sub | 0.983 |
| CYP2c19-inh | 0.393 |
| CYP2c19-sub | 0.867 |
| CYP2c9-inh | 0.584 |
| CYP2c9-sub | 0.899 |
| CYP2d6-inh | 0.056 |
| CYP2d6-sub | 0.869 |
| CYP3a4-inh | 0.375 |
| CYP3a4-sub | 0.587 |
| CL | 2.897 |
| T12 | 0.531 |
| hERG | 0.09 |
| Ames | 0.557 |
| ROA | 0.645 |
| SkinSen | 0.652 |
| Carcinogencity | 0.071 |
| EI | 0.325 |
| Respiratory | 0.12 |
| NR-Aromatase | 0.852 |
| Antiviral | Yes |
| Prediction | 0.722619 |